Historical shareholding details of
Emerald Advisers, LLC
holdings in Ultragenyx Pharmaceutical Inc. (RARE)
Monthly changes of
Emerald Advisers, LLC
shareholding in Ultragenyx Pharmaceutical Inc.
over the previous
months
Month
|
Name |
Total no. shares held |
Percent Holding |
Mar 31, 2025
|
Emerald Advisers, Llc
|
54,767
|
0.06%
|
|
Feb 28, 2025
|
Emerald Advisers, Llc
|
54,767
|
0.06%
|
|
Jan 31, 2025
|
Emerald Advisers, Llc
|
58,467
|
0.06%
|
|
Dec 31, 2024
|
Emerald Advisers, Llc
|
518,328
|
0.55%
|
Dec 31, 2024
|
Emerald Advisers, Llc
|
58,467
|
0.06%
|
|
Nov 30, 2024
|
Emerald Advisers, Llc
|
63,584
|
0.07%
|
|
Oct 31, 2024
|
Emerald Advisers, Llc
|
63,584
|
0.07%
|
|
Sep 30, 2024
|
Emerald Advisers, Llc
|
569,798
|
0.62%
|
Sep 30, 2024
|
Emerald Advisers, Llc
|
69,473
|
0.08%
|
|
Aug 31, 2024
|
Emerald Advisers, Llc
|
69,985
|
0.08%
|
|
Jul 31, 2024
|
Emerald Advisers, Llc
|
65,985
|
0.07%
|
|
Jun 30, 2024
|
Emerald Advisers, Llc
|
486,682
|
0.53%
|
Jun 30, 2024
|
Emerald Advisers, Llc
|
44,612
|
0.05%
|
|
May 31, 2024
|
Emerald Advisers, Llc
|
44,612
|
0.05%
|
|
Apr 30, 2024
|
Emerald Advisers, Llc
|
44,612
|
0.05%
|
|
Mar 31, 2024
|
Emerald Advisers, Llc
|
488,138
|
0.53%
|
Mar 31, 2024
|
Emerald Advisers, Llc
|
44,612
|
0.05%
|
|
Feb 29, 2024
|
Emerald Advisers, Llc
|
38,234
|
0.05%
|
|
Jan 31, 2024
|
Emerald Advisers, Llc
|
38,234
|
0.05%
|
|
Dec 31, 2023
|
Emerald Advisers, Llc
|
482,138
|
0.58%
|
Dec 31, 2023
|
Emerald Advisers, Llc
|
40,099
|
0.05%
|
|
Nov 30, 2023
|
Emerald Advisers, Llc
|
40,099
|
0.05%
|
|
Oct 31, 2023
|
Emerald Advisers, Llc
|
40,099
|
0.05%
|
|
Sep 30, 2023
|
Emerald Advisers, Llc
|
491,689
|
0.60%
|
Sep 30, 2023
|
Emerald Advisers, Llc
|
42,277
|
0.06%
|
|
Aug 31, 2023
|
Emerald Advisers, Llc
|
46,917
|
0.07%
|
|
Jul 31, 2023
|
Emerald Advisers, Llc
|
46,917
|
0.07%
|
|
Jun 30, 2023
|
Emerald Advisers, Llc
|
552,136
|
0.77%
|
Jun 30, 2023
|
Emerald Advisers, Llc
|
48,469
|
0.07%
|
|
May 31, 2023
|
Emerald Advisers, Llc
|
48,469
|
0.07%
|
|
Mar 31, 2023
|
Emerald Advisers, Llc
|
490,161
|
0.69%
|
View all ownership details of Ultragenyx Pharmaceutical Inc.